(VIANEWS) – NEDAP (NEDAP.AS), TotalEnergiesGabon (EC.PA), SANOFI (SAN.PA) are the highest payout ratio stocks on this list.
We have gathered information regarding stocks with the highest payout ratio at the moment. The payout ratio in itself isn’t a guarantee of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. NEDAP (NEDAP.AS)
104.53% Payout Ratio
Nedap N.V., together with its subsidiaries, develops and supplies smart technological solutions in the Netherlands, Germany, rest of Europe, North America, and internationally. The company provides software services that allow healthcare professionals to interconnect; hardware and software solutions for vehicle identification systems; and technological solutions for the dairy farming and pig farming industries. It also offers lighting solutions and UV lamp driver technologies; and RFID solutions for retailers. In addition, the company provides access control and security systems for companies and institutions. Further, it offers workforce management software, a cloud-based software for timesheet processing, employee scheduling, and access control. The company was founded in 1929 and is headquartered in Groenlo, the Netherlands.
Earnings Per Share
As for profitability, NEDAP has a trailing twelve months EPS of €2.88.
PE Ratio
NEDAP has a trailing twelve months price to earnings ratio of 20.28. Meaning, the purchaser of the share is investing €20.28 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.16%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 17, 2023, the estimated forward annual dividend rate is 3 and the estimated forward annual dividend yield is 5.26%.
More news about NEDAP.
2. TotalEnergiesGabon (EC.PA)
95.5% Payout Ratio
TotalEnergies EP Gabon Société Anonyme engages in the mining, exploration, and production of crude oil in Gabon. It also holds interests in operated and non-operated production fields. The company was formerly known as Total Gabon. The company was incorporated in 1949 and is headquartered in Port Gentil, Gabon. TotalEnergies EP Gabon Société Anonyme is a subsidiary of TotalEnergies SE.
Earnings Per Share
As for profitability, TotalEnergiesGabon has a trailing twelve months EPS of €67.39.
PE Ratio
TotalEnergiesGabon has a trailing twelve months price to earnings ratio of 2.68. Meaning, the purchaser of the share is investing €2.68 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.89%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jun 7, 2023, the estimated forward annual dividend rate is 41.22 and the estimated forward annual dividend yield is 22.75%.
More news about TotalEnergiesGabon.
3. SANOFI (SAN.PA)
50.08% Payout Ratio
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €6.69.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 14.72. Meaning, the purchaser of the share is investing €14.72 for every euro of annual earnings.
More news about SANOFI.
4. VINCI (DG.PA)
43.51% Payout Ratio
VINCI SA, together with its subsidiaries, engages in concessions, energy, and construction businesses worldwide. Its Concessions segment designs, finances, builds, and operates transport infrastructures and public equipment under public-private partnerships. The company's Energy segment provides services to the manufacturing sector, infrastructure, facilities management, and information and communication technology; and industrial and energy-related services, which includes development of renewable energy concession assets, as well as engineering, procurement, and construction projects in the energy sector. Its Construction segment engages in designing and carrying out projects, which includes general contractor; geotechnical and structural engineering and related digital activities, as well as provision of services in nuclear engineering; proximity networks with active local companies, such as building, civil engineering, roadworks, rail works, and water works; property development, including residential and commercial properties; and management of serviced residences and property services. VINCI SA was founded in 1899 and is headquartered in Nanterre, France.
Earnings Per Share
As for profitability, VINCI has a trailing twelve months EPS of €7.47.
PE Ratio
VINCI has a trailing twelve months price to earnings ratio of 14.46. Meaning, the purchaser of the share is investing €14.46 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.3%.
Moving Average
VINCI’s value is under its 50-day moving average of €108.71 and higher than its 200-day moving average of €100.64.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 25, 2023, the estimated forward annual dividend rate is 4 and the estimated forward annual dividend yield is 3.85%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 23.5%, now sitting on 62.51B for the twelve trailing months.
More news about VINCI.
5. ABN AMRO BANK N.V. (ABN.AS)
41.7% Payout Ratio
ABN AMRO Bank N.V. provides various banking products and services to retail, private, and business clients in the Netherlands and internationally. It operates through three segments: Personal & Business Banking, Wealth Management, and Corporate Banking. The company provides savings and deposits products; labelled residential mortgage products under the Florius brands; and consumer loans under the Alpha Credit Nederland, Credivance, Defam, Moneyou, and ABN AMRO brands. It also issues, promotes, manages, and processes credit cards; provides revolving credit card facilities and pension schemes, as well as consumer credit and mortgages; and life and non-life insurance products. In addition, it offers asset-based solutions, including working capital solutions, equipment leases and loans, and vendor lease services; private banking and wealth-management-related services; and derivatives and equity clearing services. ABN AMRO Bank N.V. was incorporated in 2009 and is headquartered in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, ABN AMRO BANK N.V. has a trailing twelve months EPS of €2.23.
PE Ratio
ABN AMRO BANK N.V. has a trailing twelve months price to earnings ratio of 6.92. Meaning, the purchaser of the share is investing €6.92 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.3%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 18% and a drop 28.8% for the next.
Yearly Top and Bottom Value
ABN AMRO BANK N.V.’s stock is valued at €15.44 at 07:10 EST, below its 52-week high of €17.00 and way above its 52-week low of €8.69.
Sales Growth
ABN AMRO BANK N.V.’s sales growth for the next quarter is 20%.
More news about ABN AMRO BANK N.V..
